MediPharm Labs Closes $37.8 Million Private Placement

Jun 8, 2020

MediPharm Labs Accelerates Growth of Pharma-Quality Product Portfolio With Launch of its New CBD50 Plus Formula

Jun 4, 2020

MediPharm Labs Announces Participation at Upcoming Conferences

May 29, 2020

MediPharm Labs and Argentia Gold to Bring Premium Cannabis-Infused Products to Atlantic Canada

May 27, 2020

MediPharm Labs and Ace Valley Deliver Innovative Vapes - Now Available in Several Markets Across Canada

May 25, 2020

MediPharm Labs Australia Signs First European White-Label Cannabis Supply Agreement With UK-Based Cannaray’s Therismos

May 15, 2020

MediPharm Labs Signs Wide-Ranging Strategic Manufacturing and IP Licensing Agreement with Biopharmaceutical Leader Avicanna Inc.

May 14, 2020

MediPharm Labs to File First Quarter Financial Statements and MD&A in June 2020, Provides Q1 Update

May 14, 2020

MediPharm Labs Australia Granted GMP Certificate and Licence to Manufacture Therapeutic Goods; On Track to Ramp Up and Fulfill New Supply Agreements

May 7, 2020

MediPharm Labs Australia Signs its Second GMP White-Label Deal to Supply New Zealand’s Medical Cannabis Market

May 4, 2020